These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12743 related articles for article (PubMed ID: 12234027)

  • 21. [Expressions of survivin and nm23 and the relationship among the expressions and the axillary lymph node metastasis in breast cancer].
    Mao J; Hai J; Shu HP; Wu YH; Ou HY; Luo SY; Wang SM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):312-4, 334. PubMed ID: 16045021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
    Li Y; Wu F; Gong W
    Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):177-9. PubMed ID: 11955409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression patterns of ER, HER2, and NM23-H1 in breast cancer patients with different menopausal status: correlations with metastasis.
    Dong SW; Wang L; Sui J; Deng XY; Chen XD; Zhang ZW; Liu X; Liu ZM; Zhang JH; Yang QS; Jia YF; Song X
    Mol Diagn Ther; 2011 Aug; 15(4):211-9. PubMed ID: 21913743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan.
    Mahmood H; Faheem M; Mahmood S; Sadiq M; Irfan J
    Asian Pac J Cancer Prev; 2015; 16(3):1019-24. PubMed ID: 25735323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.
    Heys SD; Langlois N; Smith IC; Walker LG; Eremin O
    Oncol Rep; 1998; 5(3):735-9. PubMed ID: 9538187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nm23 protein expression in ductal in situ and invasive human breast carcinoma.
    Royds JA; Stephenson TJ; Rees RC; Shorthouse AJ; Silcocks PB
    J Natl Cancer Inst; 1993 May; 85(9):727-31. PubMed ID: 8386774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-glycoprotein, metallothionein and NM23 protein expressions in breast carcinoma.
    Vázquez-Ramírez FJ; González-Cámpora JJ; Hevia-Alvarez E; Fernández-Santos JM; Ríos-Martín JJ; Otal-Salaverri C; González-Cámpora R
    Pathol Res Pract; 2000; 196(8):553-9. PubMed ID: 10982018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H; Mao H; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.
    Cubukcu E; Kanat O; Fatih Olmez O; Kabul S; Canhoroz M; Avci N; Deligonul A; Hartavi M; Cubukcu S; Olmez F; Kurt E; Evrensel T; Gokgoz S; Manavoglu O
    J BUON; 2013; 18(2):359-65. PubMed ID: 23818346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. nm23 Expression in choroidal melanoma.
    Bardak Y; Cekiç O; Ayhan A; Günalp I; Bulay O
    Ophthalmic Res; 2000; 32(6):257-60. PubMed ID: 11015036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
    Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
    Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms.
    Ohshio G; Imamura T; Okada N; Suwa H; Yamaki K; Imamura M; Ogasahara K; Tsukayama C; Yamabe H
    Int J Pancreatol; 1997 Aug; 22(1):59-66. PubMed ID: 9387026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
    J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.
    Han S; Yun IJ; Noh DY; Choe KJ; Song SY; Chi JG
    J Surg Oncol; 1997 May; 65(1):22-7. PubMed ID: 9179263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor.
    Saimura M; Fukutomi T; Tsuda H; Sato H; Miyamoto K; Akashi-Tanaka S; Nanasawa T
    J Surg Oncol; 1999 Jun; 71(2):101-5. PubMed ID: 10389866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
    Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
    Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 638.